ArticleEuropean journal of orthopaedic surgery & traumatology : orthopedie traumatologie2025
Outcomes of treatment for isolated greater trochanteric fractures with occult intertrochanteric extension: a retrospective cohort of 118 patients.
Article in European journal of orthopaedic surgery & traumatology : orthopedie traumatologie, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
- Erratum issued
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionIsolated greater trochanteric fractures are uncommon among the pertrochanteric femoral fractures. Magnetic resonance imaging (MRI) is recommended to confirm occult intertrochanteric extension fractures and prevent potential displacement. While treatment guidelines lack consensus, surgical intervention is suggested for intertrochanteric extension (IE) beyond the medial third portion. Our primary aim was to assess complications and functional outcomes of conservative treatment in patients with IE.
methodsIn this retrospective study, all patients aged 65 years and above with isolated greater trochanteric fractures diagnosed by X-ray were included. Subsequently, MRI divided the intertrochanteric area into lateral, medium, or medial portions based on extension proposed by Park. A minimum three-month follow-up was required. Treatment decisions, surgical or conservative, were based on surgeon criteria. Rehabilitation allowed weight-bearing as tolerated for both treatments. Analysis included demographic variables, complications, pre- and posttreatment functional status using the Parker mobility score, and overall mortality rate.
resultsFrom 2010 to 2022, 118 IGTF patients were analyzed, with a mean age of 79.8 years (SD: 11.3) and 69.5% female. Conservative treatment was performed in 93 patients (78.8%), with Park I: 8 (8.6%), Park II: 52 (55.9%), and Park III: 33 (35.5%). Surgical treatment was performed in 25 patients (21.2%), with Park I: 3 (12%), Park II: 7 (28%), and Park III: 15 (60%). The complication rate was 4.8% (n = 4) for conservative treatment (all due to secondary displacement, resolved surgically) and 4% (n = 1) for surgical treatment (deep infection). Radiological extension differed significantly by Park classification (p = 0.042). Functional outcomes (Parker scores) showed no significant changes at three months posttreatment (p = 0.177). Overall survival was 94% at three months and 90% at one year.
conclusionThis study suggests that conservative treatment is a viable option for patients with isolated greater trochanter fractures and IE, including cases involving the medial third. Decisions regarding treatment should take into account not only the location and extent of IE as identified by MRI, but also individual clinical factors.
Indexed as
Identifiers
40113608What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.